CHINOOK THERAPEUTICS, INC. Quarterly Income Tax Expense (Benefit) in USD from Q1 2015 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Chinook Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2015 to Q2 2023.
  • Chinook Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was $0.000.
  • Chinook Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2023 was $4.34M, a 53.2% increase year-over-year.
  • Chinook Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $4.34M, a 107% increase from 2021.
  • Chinook Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $2.09M.
  • Chinook Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2020 was -$2M, a 5623% decline from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $4.34M $0 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $4.34M $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $4.34M $4.34M +$1.04M +31.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-27
Q3 2022 $3.3M $0 +$463K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.83M $0 +$741K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $2.09M $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $2.09M $3.3M +$5.3M Oct 1, 2021 Dec 31, 2021 10-K 2023-02-27
Q3 2021 -$3.21M -$463K -$463K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$2.74M -$741K -$741K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$2M $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$2M -$2M -$4.29M -188% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $2.29M $0 +$2.25M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $35K $0 +$35K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $0 $0 +$35K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$35K $2.29M +$2.63M Oct 1, 2019 Dec 31, 2019 10-Q 2020-05-04
Q3 2019 -$2.66M -$2.25M -$1.87M -485% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$794K -$35K +$3K +7.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-03
Q1 2019 -$797K -$35K -$14K -66.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 -$783K -$339K +$611K +64.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-09
Q3 2018 -$1.39M -$385K +$3.49M +90.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$4.88M -$38K +$3.75M +99% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$8.63M -$21K +$2.73M +99.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$11.4M -$950K -$6.05M -119% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-09
Q3 2017 -$5.32M -$3.87M -$15.5M -133% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-30
Q2 2017 $10.2M -$3.79M -$5.26M -357% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $15.5M -$2.75M -$5.98M -185% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $21.5M $5.1M +$5.2M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $16.3M $11.7M +$11.7M Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $4.6M $1.47M +$1.47M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $3.13M $3.23M +$3.23M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 -$99K -$99K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $0 Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $0 Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.